NO20091011L - Sammensetninger med forsterket elastiserende aktivitet - Google Patents

Sammensetninger med forsterket elastiserende aktivitet

Info

Publication number
NO20091011L
NO20091011L NO20091011A NO20091011A NO20091011L NO 20091011 L NO20091011 L NO 20091011L NO 20091011 A NO20091011 A NO 20091011A NO 20091011 A NO20091011 A NO 20091011A NO 20091011 L NO20091011 L NO 20091011L
Authority
NO
Norway
Prior art keywords
composition
compositions
vagina
birth
risk
Prior art date
Application number
NO20091011A
Other languages
English (en)
Other versions
NO343143B1 (no
Inventor
Federico Mailland
Paolo Mascarucci
Emanuela Mura
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of NO20091011L publication Critical patent/NO20091011L/no
Publication of NO343143B1 publication Critical patent/NO343143B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Oppfinnelsen omfatter en sammensetning for å forbedre elastisiteten av vagina og perineum i siste trimester under graviditet som omfatter å kombinere minst en tiolert forbindelse og minst en ester av en organisk syre eller en blanding der av. Sammensetningen ifølge foreliggende oppfinnelse forbedrer de elastiske egenskapene til vagina og/eller de perinale vevene når det gjelder utvidelsesevne og raskere elastisk restitusjon. Sammensetningen ifølge foreliggende oppfinnelse kan redusere risikoen for skade på perineale vev ved fødselen og redusere faren for rektal- og blæreinkontinens som en komplikasjon etter fødselen.
NO20091011A 2006-08-09 2009-03-06 Anvendelse av karboksymetylcystein inneholdende sammensetning NO343143B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20060118649 EP1886676A1 (en) 2006-08-09 2006-08-09 Compositions with enhanced elasticizing activity
PCT/EP2007/053793 WO2008017521A2 (en) 2006-08-09 2007-04-18 Compositions with enhanced elasticizing activity

Publications (2)

Publication Number Publication Date
NO20091011L true NO20091011L (no) 2009-03-06
NO343143B1 NO343143B1 (no) 2018-11-19

Family

ID=37575000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091011A NO343143B1 (no) 2006-08-09 2009-03-06 Anvendelse av karboksymetylcystein inneholdende sammensetning

Country Status (23)

Country Link
US (1) US9125806B2 (no)
EP (2) EP1886676A1 (no)
JP (2) JP2010500309A (no)
KR (2) KR101521166B1 (no)
CN (1) CN101500550B (no)
AR (1) AR062304A1 (no)
AT (1) ATE457723T1 (no)
BR (1) BRPI0715182C1 (no)
CA (1) CA2655472C (no)
CY (1) CY1110032T1 (no)
DE (1) DE602007004857D1 (no)
DK (1) DK2049092T3 (no)
EA (1) EA014971B1 (no)
ES (1) ES2340335T3 (no)
HK (1) HK1126956A1 (no)
HR (1) HRP20100212T1 (no)
MX (1) MX2009000869A (no)
NO (1) NO343143B1 (no)
PL (1) PL2049092T3 (no)
PT (1) PT2049092E (no)
RS (1) RS51282B (no)
SI (1) SI2049092T1 (no)
WO (1) WO2008017521A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3081212A1 (en) 2015-04-16 2016-10-19 Polichem SA Carboxymethylcysteine for topical treatment of stretch marks
EP3442501A1 (en) 2016-04-15 2019-02-20 Fairhaven Health, LLC Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract
IT202100002285A1 (it) * 2021-02-03 2022-08-03 Farm Dott Ferretti Stefano Nuova composizione

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617639A1 (de) * 1966-09-12 1972-04-20 Mini Ind Chimice Verfahren zur Herstellung eines Arzneimittels zur Behandlung von physiologischen Hautkrankheiten
US4296130A (en) * 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use
GB9213472D0 (en) * 1992-06-25 1992-08-12 Unilever Plc Cosmetic composition
WO1995034280A1 (en) * 1994-06-15 1995-12-21 The Procter & Gamble Company Methods of lightening hyperpigmented regions in mammalian skin
JP3542665B2 (ja) * 1995-07-07 2004-07-14 株式会社資生堂 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤
FR2740340B1 (fr) * 1995-10-30 1997-12-05 Oreal Utilisation d'acides carboxyliques porteurs d'une fonction soufree pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
US20050266064A1 (en) * 2004-05-29 2005-12-01 Mccarthy Kathryn J Cosmetic compositions and methods
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
US7087560B2 (en) * 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
BRPI0515846B1 (pt) * 2004-10-25 2020-10-20 Unilever N.V composição de higiene pessoal
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
US7351745B2 (en) * 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin

Also Published As

Publication number Publication date
BRPI0715182A2 (pt) 2012-12-25
HRP20100212T1 (hr) 2010-05-31
ATE457723T1 (de) 2010-03-15
EA014971B1 (ru) 2011-04-29
EP2049092A2 (en) 2009-04-22
CY1110032T1 (el) 2015-01-14
SI2049092T1 (sl) 2010-04-30
DE602007004857D1 (de) 2010-04-01
HK1126956A1 (en) 2009-09-18
KR20090050065A (ko) 2009-05-19
JP2010500309A (ja) 2010-01-07
WO2008017521A3 (en) 2008-05-22
CN101500550A (zh) 2009-08-05
NO343143B1 (no) 2018-11-19
CA2655472C (en) 2014-10-21
PT2049092E (pt) 2010-04-21
JP5771649B2 (ja) 2015-09-02
EP2049092B1 (en) 2010-02-17
US20090291931A1 (en) 2009-11-26
CN101500550B (zh) 2011-12-14
JP2013227334A (ja) 2013-11-07
BRPI0715182B1 (pt) 2020-07-28
KR101521166B1 (ko) 2015-05-19
PL2049092T3 (pl) 2010-07-30
BRPI0715182B8 (pt) 2020-08-11
EA200900293A1 (ru) 2009-06-30
AR062304A1 (es) 2008-10-29
RS51282B (sr) 2010-12-31
WO2008017521A2 (en) 2008-02-14
EP1886676A1 (en) 2008-02-13
KR20140046080A (ko) 2014-04-17
CA2655472A1 (en) 2008-02-14
MX2009000869A (es) 2009-02-04
BRPI0715182C1 (pt) 2021-05-25
ES2340335T3 (es) 2010-06-01
DK2049092T3 (da) 2010-05-10
US9125806B2 (en) 2015-09-08

Similar Documents

Publication Publication Date Title
AU2015213344B2 (en) Novel CC-1065 analogs and their conjugates
WO2008060622A3 (en) Improved methods and compositions for wound healing
BRPI0813140C1 (pt) método para a preparação de ácido desoxicólico (dca) ou um éster desse ou um sal farmaceuticamente aceitável desse e composto intermediário
WO2007073398A3 (en) Compositions and methods for the sustained release of beta-alanine
BR112012013544A2 (pt) método para cimentação em uma formação subterrânea, e, composição para uso em uma formação subterrânea.
NO20091011L (no) Sammensetninger med forsterket elastiserende aktivitet
BR112012016311A2 (pt) ferramenta multifuncional utilizável em um procedimento para instalar um implante pélvico
JOP20180077A1 (ar) تركيبات وطرق لحمض صفراوي تخليقي
WO2006023966A3 (en) Assessment of cardiovascular risk
ATE542517T1 (de) Haftzusammensetzung für hartes gewebe
ECSP088888A (es) Antagonistas del receptor de vanilloides del subtipo (vr1)
DK2094325T3 (da) Fremstilling af væv til meniskimplantation
MX2009011387A (es) Estimulantes de la gcs, activadores de la gcs y combinaciones para el tratamiento de trastornos urologicos.
WO2006108023A3 (en) Methods and compositions for modulating necdin function
BRPI0917694A2 (pt) Metodos para tracionar tecido sub-uretral, e para prover tracionamento bilateral para tratar um disturbio pelvico, e, sistema de implante pelvico
WO2008157060A3 (en) Human umbilical tissue-derived cell compositions for the treatment of incontinence
WO2009124653A3 (de) Thienopyrimidine
Wagenlehner et al. Perineal body repair in patients with third degree rectocele: a critical analysis of the tissue fixation system
MX2020006892A (es) Composiciones para crioconservación y métodos de uso de estas.
MX2023007287A (es) N-(2-(4-cianotiazolidin-3-il)-2-oxoetil)-quinolin-4-carboxamidas.
WO2008011524A3 (en) Method of using mitotically inactivated stem cells for damaged tissue repair
WO2011143752A8 (en) Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal
BR112012010392A2 (pt) composição, método e kit para o inibidor de alfa-1 proteinase
MX2009002228A (es) Composiciones y metodos para tratar o prevenir glaucoma o el avance del mismo.
Lauterbach et al. Single-port versus multi-port robotic sacrocervicopexy: Establishment of a learning curve and short-term outcomes